CBO: 'Research & Development in Pharmaceutical Industry' (Part 1 of 2)
April 09, 2021
April 09, 2021
WASHINGTON, April 9 -- The Congressional Budget Office issued the following report entitled "Research and Development in the Pharmaceutical Industry":
At a Glance
This report examines research and development (R&D) by the pharmaceutical industry.
Spending on R&D and Its Results. Spending on R&D and the introduction of new drugs have both increased in the past two decades.
* In 2019, the pharmaceutical industry spent $83 bi . . .
At a Glance
This report examines research and development (R&D) by the pharmaceutical industry.
Spending on R&D and Its Results. Spending on R&D and the introduction of new drugs have both increased in the past two decades.
* In 2019, the pharmaceutical industry spent $83 bi . . .